By [Your Name/Journalistic Staff]
June 01, 2026
For decades, the public consciousness surrounding BRCA mutations—specifically BRCA1 and BRCA2—has been almost exclusively tethered to women’s health. The prevailing narrative often centers on breast and ovarian cancer awareness, leaving a significant demographic out of the conversation: men.
Doug Bank, a long-time cancer advocate and member of the Sharsheret Men’s Leadership Council, knows this oversight all too well. His personal journey, spanning from a youthful testicular cancer diagnosis to a BRCA2-related prostate cancer diagnosis at 56, serves as a poignant reminder that genetic risk knows no gender. By breaking the silence on hereditary cancer, Bank and other advocates are rewriting the script on how families approach genetic testing, screening, and survival.
The Chronology of a Genetic Legacy
Doug Bank’s path to advocacy began in 1997, when at age 26, he was diagnosed with Stage I testicular cancer. At the time, the diagnosis felt like an isolating, overwhelming ordeal. Following surgery, he was pressured into aggressive treatment protocols that he later realized were medically unnecessary for his specific prognosis. This period of confusion sparked a lifelong commitment to patient advocacy, leading him to co-found support groups and collaborate with the LIVESTRONG Young Adult Alliance.
It was during these early years of advocacy that Bank first crossed paths with the late Rochelle Shoretz, founder of Sharsheret, a national organization supporting Jewish women and families facing breast and ovarian cancer. Little did he know that their professional acquaintance would eventually become a personal lifeline.
The turning point occurred several years later when his wife’s physician began a standard inquiry into family health history. While his wife’s history was relatively clear, Bank’s was not. His father had battled prostate cancer, an aunt had breast cancer, and his grandmother had died from a malignancy before he was born. Despite his background in cancer advocacy, Bank initially resisted the suggestion of genetic testing.
"Eventually, I gave in," Bank recalls. "I knew enough to create a family tree, or what doctors call a pedigree, to document the cancer in my family. That is when the pattern became much harder to ignore."
By 2009, Bank confirmed he carried a BRCA2 mutation. The subsequent years revealed the devastating reach of the gene: his brother was diagnosed with pancreatic cancer—a condition strongly linked to BRCA2. Although his brother did not survive, the genetic knowledge allowed the family to manage his care more effectively, providing them with precious additional time.
The most critical impact of this knowledge came when Bank’s daughter, then 24, discovered a lump. Because the family knew of the BRCA2 mutation, there was no delay, no "watchful waiting," and no dismissal from medical professionals. She received immediate, specialized care, proving that in the context of hereditary cancer, knowledge is not merely power—it is life-saving.
Understanding the BRCA Mutation: Beyond the Gender Binary
To understand why men must be part of the BRCA conversation, one must first look at the biology. BRCA genes are tumor suppressor genes. When they function correctly, they help repair damaged DNA. When they are mutated, however, that repair mechanism fails, significantly increasing the risk of cellular mutations that lead to cancer.
The Risks for Men
While breast cancer in men is rare, it is significantly more common in those who carry a BRCA2 mutation. Furthermore, BRCA mutations are explicitly linked to:
- Prostate Cancer: Often more aggressive in carriers of the mutation.
- Pancreatic Cancer: A high-mortality cancer where early detection remains a significant medical challenge.
- Melanoma: Increased risk profiles have been identified in specific genetic subsets.
"Calling BRCA a women’s issue misses half the story," Bank asserts. "Men can carry these mutations. Men can develop related cancers. Men can pass the risk to their children. And sometimes, men are the link that helps a family finally understand what has been happening across generations."
The Psychological Burden of Genetic Testing
One of the most persistent barriers to testing is the "anxiety factor." Many individuals, including medical professionals, often hesitate to test younger family members, fearing that a positive result will introduce unnecessary psychological strain.
Bank’s experience highlights the flaw in this logic. "The doctors didn’t really want to test [my children] because they were too young," he explains. "The doctors did not seem to realize that not knowing whether you have a mutation when your parent does have one can also cause anxiety."
The clinical consensus is shifting. Genetic counselors now emphasize that the "unknown" is often a source of chronic, low-level anxiety that can be replaced by actionable, data-driven health management. When a family knows their status, they can move from a state of passive fear to a state of active prevention.
Implications for Public Health and Family Advocacy
The implications of Bank’s story for the broader medical community are twofold: the need for better physician education and the necessity of normalizing male participation in genetic counseling.
1. Physician Education and Pedigree Mapping
General practitioners and specialists alike must move beyond the "breast cancer is a woman’s disease" heuristic. Comprehensive family history taking—documenting both maternal and paternal lineages—is essential. As Bank’s case illustrates, looking at the paternal side of the family is what finally illuminated the pattern of BRCA2 transmission.
2. The Role of Support Organizations
Organizations like Sharsheret are bridging the gap by providing resources that transcend gender lines. By incorporating men into their leadership and support networks, these groups acknowledge that a cancer diagnosis is a family event. When a man learns he is a carrier, he is not just learning about his own health; he is learning about the health of his sisters, his daughters, and his future generations.
3. The "Actionable Knowledge" Paradigm
The medical community must refine its approach to screening. For those with a known mutation, the standard of care should include:
- Prostate screenings starting at a younger age for men.
- Pancreatic surveillance in clinical trial or high-risk monitoring settings.
- Genetic counseling as a routine component of family health check-ups.
Conclusion: A Call for Inclusive Conversation
As Doug Bank continues his work with the Sharsheret Men’s Leadership Council, his message remains clear: Men must not stand on the sidelines. The stigma of "male-specific" cancers or the belief that genetic mutations are "feminine" health issues are outdated concepts that cost lives.
"Genetic information can create anxiety. I understand that," Bank reflects. "But not knowing does not make the risk go away. It only leaves families with fewer chances to act."
The reality of hereditary cancer is that it is a family story, not an individual one. Whether it is through the identification of a multi-generational pattern, the support provided during treatment, or the proactive surveillance of children, men play a critical role in the fight against cancer. By engaging in honest, transparent conversations and pursuing genetic testing when family history suggests it, men can transition from being silent carriers to empowered protectors of their family’s future health.
As the medical field continues to advance, the hope is that the stories of men like Doug Bank will shift from being the exception to the rule—a catalyst for a new era of inclusive, proactive, and life-saving cancer care.
About the Author
